REL:LSERELX PLC Analysis
Data as of 2026-08-25 - not real-time
£2,618.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
At £2,618.00, RELX PLC shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it gained 7.1%. Momentum indicators put RSI at 53.7 (neutral) with MACD reading bearish. Watch £2,459.00 as support and £2,886.00 as the nearer resistance level.
On valuation the read is fair — earnings multiple of 20.9 versus a 29.6 sector average, below the peer group. Sell-side targets cluster 29.5% above the current quote. Revenue is growing at 2.7% on a 23.3% profit margin. The 2.60% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 41.6%, a beta of 0.21 and a maximum drawdown of 43.5%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
On valuation the read is fair — earnings multiple of 20.9 versus a 29.6 sector average, below the peer group. Sell-side targets cluster 29.5% above the current quote. Revenue is growing at 2.7% on a 23.3% profit margin. The 2.60% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 41.6%, a beta of 0.21 and a maximum drawdown of 43.5%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Top Market Events
RELX LSE:REL delivered a strong set of first-half results for 2026, with underlying growth across all four of its core...RELX PLC LSE:REL shares rose 1.5% to 2,491p on Thursday after the FTSE 100 group delivered higher first-half revenue...LONDON dpa-AFX - RELX Plc RELX, RLXXF.PK, REL.L , a provider of information-based analytics and decision tools,...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 2643.74
- MACD momentum is negative
- 30-day price change of +7.1%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 20.9 versus sector average of 29.6
- Trading below the 200-day average of 2643.74
- Analyst targets imply +29.5% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 20.9 versus sector average of 29.6
- Analyst targets imply +29.5% versus the current price
- Profit margin of 23.3% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth2.70%
Profit Margin23.27%
P/E Ratio20.9
ROE131.86%
ROA13.12%
Debt/Equity709.64
P/B Ratio37.0
Op. Cash Flow£2.9B
Free Cash Flow£2.2B
Industry P/E29.6
Technical Analysis
TrendNeutral
RSI53.7
Support£2,459.00
Resistance£2,886.00
MA 20£2,613.20
MA 50£2,508.36
MA 200£2,643.74
MACDBearish
VolumeDecreasing
Fear & Greed Index93.71
Valuation
Fair Value£1,331.48
Target Price£3,391.24
Upside/Downside29.54%
GradeFair
TypeBlend
Dividend Yield2.60%
Risk Assessment
Beta0.21
Volatility41.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.